Muhlenkamp & Co. Inc. raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.0% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 59,024 shares of the healthcare conglomerate’s stock after purchasing an additional 4 shares during the quarter. UnitedHealth Group comprises approximately 3.4% of Muhlenkamp & Co. Inc.’s holdings, making the stock its 9th biggest holding. Muhlenkamp & Co. Inc.’s holdings in UnitedHealth Group were worth $10,944,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Regal Wealth Group Inc. boosted its holdings in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after purchasing an additional 3 shares during the last quarter. Jackson Grant Investment Advisers Inc. boosted its holdings in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock valued at $204,000 after purchasing an additional 4 shares during the last quarter. RB Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 0.4% in the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after purchasing an additional 7 shares during the last quarter. Altfest L J & Co. Inc. boosted its holdings in shares of UnitedHealth Group by 0.3% in the 2nd quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock valued at $549,000 after purchasing an additional 10 shares during the last quarter. Finally, Hanson McClain Inc. boosted its holdings in shares of UnitedHealth Group by 1.7% in the 1st quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $147,000 after purchasing an additional 15 shares during the last quarter. Institutional investors own 85.71% of the company’s stock.

In related news, insider Thomas E. Roos sold 975 shares of UnitedHealth Group stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the sale, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the sale, the director now directly owns 60,834 shares in the company, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. Insiders have sold a total of 57,606 shares of company stock worth $11,433,133 in the last ninety days. 0.89% of the stock is currently owned by insiders.

A number of equities analysts have weighed in on UNH shares. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Cowen Inc reiterated an “outperform” rating and issued a $220.00 price target (up previously from $175.00) on shares of UnitedHealth Group in a report on Friday, August 11th. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a report on Thursday, August 17th. Jefferies Group LLC reiterated a “buy” rating and issued a $215.00 price target on shares of UnitedHealth Group in a report on Friday, August 18th. Finally, UBS AG reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. Three research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $216.65.

UnitedHealth Group Incorporated (NYSE:UNH) traded up $0.41 during trading on Monday, reaching $212.92. 1,043,122 shares of the company traded hands, compared to its average volume of 3,087,542. UnitedHealth Group Incorporated has a 12-month low of $150.00 and a 12-month high of $213.93. The stock has a market cap of $205,936.64, a P/E ratio of 22.14, a price-to-earnings-growth ratio of 1.58 and a beta of 0.64. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. During the same quarter in the previous year, the firm posted $2.17 EPS. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. sell-side analysts predict that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.41%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is 33.26%.

ILLEGAL ACTIVITY NOTICE: “Muhlenkamp & Co. Inc. Has $10.94 Million Holdings in UnitedHealth Group Incorporated (UNH)” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this story on another site, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/muhlenkamp-co-inc-has-10-94-million-holdings-in-unitedhealth-group-incorporated-unh/1729386.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.